Malformations detected by abdominal ultrasound in children with congenital heart disease.

Autor: Rosa RC; Programa de Pós-graduação em Patologia, Fundação Universidade Federal de Ciências da Saúde de Porto Alegre, RS, Brasil., Rosa RF, Flores JA, Golendziner E, Oliveira CA, Varella-Garcia M, Paskulin GA, Zen PR
Jazyk: English; Portuguese
Zdroj: Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2012 Dec; Vol. 99 (6), pp. 1092-9. Date of Electronic Publication: 2012 Nov 30.
DOI: 10.1590/s0066-782x2012005000111
Abstrakt: Background: Extracardiac malformations may be present in patients with congenital heart disease (CHD), bringing greater risk of comorbidity and mortality.
Objective: Verify frequency and types of abdominal abnormalities detected in children with and without CHD through abdominal ultrasound (AUS), compare the patients in relation to their dysmorphic/cytogenetic findings and perform an estimative of the cost-effectiveness of the screening through AUS.
Methods: We conducted a cross-sectional study with a control cohort. The cases consisted of patients with CHD admitted for the first time in a pediatric intensive care unit; the controls consisted of children without CHD who underwent AUS at the hospital shortly thereafter a case. All patients with CHD underwent AUS, high-resolution karyotype and fluorescence in situ hybridization (FISH) for microdeletion 22q11.2.
Results: AUS identified clinically significant abnormalities in 12.2% of the cases and 5.2% of controls (p= 0.009), with a power of significance of 76.6%. Most malformations with clinical significance were renal anomalies (10.4% in cases and 4.9% in controls; p= 0.034). In Brazil, the cost of an AUS examination for the Unified Health System is US$ 21. Since clinically significant abnormalities were observed in one in every 8.2 CHD patients, the cost to identify an affected child was calculated as approximately US$ 176.
Conclusion: Patients with CHD present a significant frequency of abdominal abnormalities detected by AUS, an inexpensive and noninvasive diagnostic method with good sensitivity. The cost of screening for these defects is considerably lower than the cost to treat the complications of late diagnoses of abdominal malformations such as renal disease.
Databáze: MEDLINE